Insider · CIK 0001823682
Dirk Kersten
director
Files at DYN (Dyne Therapeutics, Inc.). First filing Oct 18, 2024, latest Mar 13, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $29M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DYN: Dyne Therapeutics, Inc.
DYNOct 9, 2026 · close 16.64
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Dyne Therapeutics, Inc. | $2.5M 129,672 shares | -3% | +194% from low-18% from high | |
| 40Moderate | Dyne Therapeutics, Inc. | $13M 688,788 shares | -13% | +160% from low-27% from high | |
| 55Moderate | Dyne Therapeutics, Inc. | $4.0M 136,112 shares | -2% | - | |
| 55Moderate | Dyne Therapeutics, Inc. | $4.1M 138,845 shares | -2% | - | |
| 55Moderate | Dyne Therapeutics, Inc. | $3.3M 110,933 shares | -2% | - | |
| 40Moderate | Dyne Therapeutics, Inc. | $674k 19,732 shares | -27% | - | |
| 18Weak | Dyne Therapeutics, Inc. | $476k 13,535 shares | -16% | - | |
| 30Weak | Dyne Therapeutics, Inc. | $1.3M 36,684 shares | -30% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -129,672 | $19.52 | $2.5M | 4,644,386 | Mar 13, 2026 |
| Mar 9, 2026 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -177,690 | $17.72 | $3.1M | 5,285,156 | Mar 11, 2026 |
| Mar 10, 2026 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -9,482 | $18.21 | $173k | 5,275,674 | Mar 11, 2026 |
| Mar 10, 2026 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -219,758 | $19.33 | $4.2M | 5,055,916 | Mar 11, 2026 |
| Mar 10, 2026 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -281,858 | $19.80 | $5.6M | 4,774,058 | Mar 11, 2026 |
| May 30, 2025 | DYN Dyne Therapeutics, Inc. | AGrant or award Stock option (right to buy)derivative | +35,000 | $0.00 | $0 | 35,000 | Jun 3, 2025 |
| Dec 6, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -101,675 | $29.34 | $3.0M | 5,434,982 | Dec 10, 2024 |
| Dec 9, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -34,437 | $29.18 | $1.0M | 5,400,545 | Dec 10, 2024 |
| Dec 4, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -135,039 | $29.39 | $4.0M | 5,540,463 | Dec 6, 2024 |
| Dec 5, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -3,806 | $29.05 | $111k | 5,536,657 | Dec 6, 2024 |
| Dec 2, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -79,973 | $29.66 | $2.4M | 5,706,462 | Dec 4, 2024 |
| Dec 2, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -1,228 | $30.37 | $37k | 5,705,234 | Dec 4, 2024 |
| Dec 3, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -29,732 | $29.05 | $864k | 5,675,502 | Dec 4, 2024 |
| Nov 13, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -10,803 | $35.24 | $381k | 62,301 | Nov 15, 2024 |
| Nov 14, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -8,929 | $32.82 | $293k | 5,786,435 | Nov 15, 2024 |
| Oct 18, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -13,414 | $35.16 | $472k | 73,225 | Oct 22, 2024 |
| Oct 21, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -121 | $35.06 | $4,242 | 73,104 | Oct 22, 2024 |
| Oct 16, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -23,671 | $35.35 | $837k | 99,652 | Oct 18, 2024 |
| Oct 17, 2024 | DYN Dyne Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote10b5-1 | -13,013 | $35.17 | $458k | 86,639 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.